Untangling the complex interplay between eating disorders, gut–brain disorders and motility disorders is challenging. Nationally and internationally, there has been a concerning increase in patients receiving artificial nutrition that may be unnecessary.1 This places patients at risk of iatrogenic harm and results in considerable economic burden to health services. There is a clear need for high quality research to guide care, but in its absence, now more than ever, we require a national treatment consensus to support clinicians working in this field. This article aims to highlight the current status, knowledge, and service limitations in treating this difficult cohort of patients, and make recommendations on future strategies within Australia to move forward for better patient outcomes.
The full article is accessible to AMA members and paid subscribers. Login to read more or purchase a subscription now.
Please note: institutional and Research4Life access to the MJA is now provided through Wiley Online Library.
- 1. Lal S, Paine P, Tack J, et al. Avoiding the use of long‐term parenteral support in patients without intestinal failure: a position paper from the European Society of Clinical Nutrition & Metabolism, the European Society of Neurogastroenterology and Motility and the Rome Foundation for Disorders of Gut‐Brain Interaction. Neurogastroenterol Motil 2024; 36: e14853.
- 2. Emmanuel AV, Stern J, Treasure J, et al. Anorexia nervosa in gastrointestinal practice. Eur J Gastroenterol Hepatol 2004; 16: 1135‐1142.
- 3. Hollis E, Murray HB, Parkman HP. Relationships among symptoms of gastroparesis to those of avoidant/restrictive food intake disorder in patients with gastroparesis. Neurogastroenterol Motil 2024; 36: e14725.
- 4. Schalla MA, Stengel A. Gastrointestinal alterations in anorexia nervosa ‐ a systematic review. Eur Eat Disord Rev 2019; 27: 447‐461.
- 5. Murray HB, Bailey AP, Keshishian AC, et al. Prevalence and characteristics of avoidant/restrictive food intake disorder in adult neurogastroenterology patients. Clin Gastroenterol Hepatol 2020; 18: 1995‐2002.
- 6. Peters JE, Basnayake C, Hebbard GS, et al. Prevalence of disordered eating in adults with gastrointestinal disorders: a systematic review. Neurogastroenterol Motil 2022; 34: e14278.
- 7. Gallo R, Armstrong E, Griffin H, et al. Impact of enteral tube feeding for individuals with disorders of the gut brain interaction. Clin Nutr ESPEN 2023; 58: 604.
- 8. Martin LD, Wang X, Day C, et al. Enteral tube feeding in functional gastrointestinal disorders: a game of chance? Clin Nutr ESPEN 2023; 57: 849.
- 9. Gillanders L, Angstmann K, Ball P, et al. AuSPEN clinical practice guideline for home parenteral nutrition patients in Australia and New Zealand. Nutrition 2008; 24: 998‐1012.
- 10. Camilleri M, Kuo B, Nguyen L, et al. ACG clinical guideline: gastroparesis. Am J Gastroenterol 2022; 117: 1197‐1220.
- 11. Cobbaert L, Hay P, Mitchell PB, et al. Sensory processing across eating disorders: a systematic review and meta‐analysis of self‐report inventories. Int J Eat Disord 2024; 57: 1465‐1488.
- 12. Chiarioni G, Bassotti G, Monsignori A, et al. Anorectal dysfunction in constipated women with anorexia nervosa. Mayo Clin Proc 2000; 75: 1015‐1019.
- 13. Joyeux MA, Pierre A, Barrois M, et al. Stomach size in anorexia nervosa: a new challenge? Eur Eat Disord Rev 2024; 32: 784‐794.
- 14. West M, McMaster CM, Staudacher HM, et al. Gastrointestinal symptoms following treatment for anorexia nervosa: a systematic literature review. Int J Eat Disord 2021; 54: 936‐951.
- 15. Riedlinger C, Schmidt G, Weiland A, et al. Which symptoms, complaints and complications of the gastrointestinal tract occur in patients with eating disorders? A systematic review and quantitative analysis. Front Psychiatry 2020; 11: 195.
- 16. Andreani NA, Sharma A, Dahmen B, et al. Longitudinal analysis of the gut microbiome in adolescent patients with anorexia nervosa: microbiome‐related factors associated with clinical outcome. Gut Microbes 2024; 16: 2304158.
- 17. Powell N, Walker MM, Talley NJ. The mucosal immune system: master regulator of bidirectional gut‐brain communications. Nat Rev Gastroenterol Hepatol 2017; 14: 143‐159.
- 18. Aguilera‐Lizarraga J, Hussein H, Boeckxstaens GE. Immune activation in irritable bowel syndrome: what is the evidence? Nat Rev Immunol 2022; 22: 674‐686.
- 19. Simons J, Shajee U, Palsson O, et al. Disorders of gut‐brain interaction: highly prevalent and burdensome yet under‐taught within medical education. United European Gastroenterol J 2022; 10: 736‐744.
- 20. Denman E, Parker EK, Ashley MA, et al. Understanding training needs in eating disorders of graduating and new graduate dietitians in Australia: an online survey. J Eat Disord 2021; 9: 27.
- 21. Knowles SR, Apputhurai P, Palsson OS, et al. The epidemiology and psychological comorbidity of disorders of gut–brain interaction in Australia: results from the Rome Foundation Global Epidemiology Study. Neurogastroenterol Motil 2023; 35: e14594.
Correspondence: rbwh‐nmc‐admin@health.qld.gov.au
Nicholas Talley is the Emeritus Editor‐In‐Chief of the MJA. We confirm that he was not involved in any review, decision making, or editorial processes for this manuscript.